TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Aspira Women’s Health ( (AWHL) ) just unveiled an update.
On September 2, 2025, Aspira Women’s Health appointed Brian Hungerford as its Chief Financial Officer and Principal Accounting Officer, replacing Julie Carrillo. Hungerford, with over 20 years of experience, previously served as CFO for Kiromic Biopharma, Inc. His compensation package includes a $300,000 annual salary, a potential 35% cash bonus, and stock options. The Consulting Agreement outlines terms for salary continuation and stock option vesting in the event of termination without cause or following a change of control.
The most recent analyst rating on (AWHL) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Aspira Women’s Health stock, see the AWHL Stock Forecast page.
Spark’s Take on AWHL Stock
According to Spark, TipRanks’ AI Analyst, AWHL is a Neutral.
The company’s challenging financial position, marked by unprofitability and negative equity, significantly impacts its stock score. While technical indicators show some positive momentum, the lack of profitability and adverse corporate events weigh heavily on the overall assessment.
To see Spark’s full report on AWHL stock, click here.
More about Aspira Women’s Health
Average Trading Volume: 117,088
Technical Sentiment Signal: Sell
Current Market Cap: $14.77M
See more data about AWHL stock on TipRanks’ Stock Analysis page.